Aurobindo receives FDA green light for generic SabrilVigabatrin for oral solution has an estimated market size of $262.5 million for the 12 months ended July 2021, according to IQVIA. Breckenridge receives FDA OK for generic AubagioAubagio had a market value of roughly $1.9 billion during the 12 months ended July 2021, according to industry sales data. Upsher-Smith intros three new dosage strengths for generic Absorica Upsher-Smith is partnering with Mayne Pharma to expand product access. FDA approves Samsung Bioepis’ Lucentis biosimilar Byooviz, which is the first biosimilar to Lucentis, provides a treatment for several eye diseases and conditions. Zydus Cadila gets FDA blessing for generic Otezla Zydus Cadila’s generic Otezla provides treatment for adults with moderate to severe plaque psoriasis. Hikma to acquire Custopharm Custopharm, a generic sterile injectables company, markets its products through Leucadia Pharmaceuticals. Aurobindo obtains FDA nod for generic Tricor Aurobindo's fenofibrate capsules will be available in dosage strengths of 67 mg, 134 mg and 200 mg. Glenmark gets FDA green light for generic Evoclin Evoclin Foam had a market value of approximately $12 million for the 12 months endedJuly 2021, according to IQVIA. Par intros generic Chantix Chantix had a market value of approximately $1 billion for the 12 months ended June 30, according to IQVIA. Camber debuts generic Bystolic Camber's nebivolol tablets provide a generic treatment for patients with hypertension. First Previous 103 104 105 106 107 Next Last
